Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT04714593
Status:
UNKNOWN
Last Update Posted:
2021-01-22
First Post:
2021-01-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia
Sponsor:
Shanxi Province Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-07
First Submit QC Date:
None
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-17
Last Update Post Date:
2021-01-22
Last Update Post Date Type:
ACTUAL